We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Lexeo Therapeutics Inc | NASDAQ:LXEO | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.60 | 4.03% | 15.49 | 12.68 | 16.51 | 15.63 | 14.355 | 14.76 | 113,566 | 22:57:10 |
From Jul 2023 to Jul 2024
The event will be webcast live under the News & Events tab in the Investors section of the Company’s website. A replay of the webcast will be available after the conclusion of the live presentation.
About Lexeo TherapeuticsLexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease are treated. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4-associated Alzheimer’s disease programs.
Media Response:Janine Bogris(201) 245-6838janine.bogris@canalecomm.com
Investor Response:Laurence Watts(619) 916-7620laurence@gilmartinir.com
1 Year Lexeo Therapeutics Chart |
1 Month Lexeo Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
